This video provides a detailed overview of various antifungal drug mechanisms of action, focusing on how these agents target different components of the fungal cell to achieve therapeutic effects. It begins by explaining the crucial role of ergosterol in maintaining fungal plasma membrane integrity, akin to cholesterol in humans, and then describes how drugs like azoles (e.g., clotrimazole, fluconazole) and terbinafine inhibit different enzymatic steps in its synthesis pathway. The discussion extends to drugs that disrupt the fungal cell wall, such as echinocandins (e.g., caspofungin), by inhibiting beta-glucan synthase. Furthermore, the video covers agents like amphotericin B and nystatin, which directly create pores in the ergosterol-containing plasma membrane, and those that interfere with nuclear processes and DNA, specifically flucytosine and griseofulvin. The presenter also offers memorable mnemonics for each drug class's mechanism and highlights critical side effects of amphotericin B, including phlebitis, recurrent fever/chills, and nephrotoxicity.
Fungal Cell Targets and Antifungal Drug Mechanisms
0:00 Fungal Cell Membrane Integrity & Ergosterol: The video introduces the fungal cell and "ergosterol," a cholesterol-like component essential for the structural integrity of its plasma membrane.
0:36 Ergosterol Synthesis Pathway: Ergosterol is synthesized through a pathway starting with squalene, converted to squalene epoxide, then lanosterol, and finally ergosterol.
1:16 Azoles: Inhibiting Ergosterol Formation (Late Stage): Drugs ending in "-azole" (e.g., clotrimazole, fluconazole) inhibit the enzyme 14-alpha demethylase, preventing the conversion of lanosterol to ergosterol. This destabilizes the fungal plasma membrane, leading to cell death.
2:20 Terbinafine: Inhibiting Ergosterol Formation (Early Stage): Terbinafine inhibits squalene epoxidase, an enzyme in the initial step of ergosterol synthesis (squalene to squalene epoxide), thereby preventing ergosterol formation and causing similar membrane instability.
3:14 Fungal Cell Wall & Beta Glucans: The fungal cell also has an outer cell wall, primarily made of beta glucans, which are activated and processed by the enzyme beta-glucan synthase.
4:14 Echinocandins: Inhibiting Cell Wall Synthesis: Drugs ending in "-fungin" (e.g., caspofungin) inhibit beta-glucan synthase, preventing the formation of structural components for the fungal cell wall and leading to fungal cell death.
4:57 Amphotericin B & Nystatin: Direct Membrane Disruption: These powerful antifungals act directly on ergosterol, wedging themselves into the plasma membrane to create holes or tears, which disrupts cell integrity and causes cell death. Amphotericin B is used for severe systemic infections, while nystatin is used for more localized infections.
Echinocandins: "He kinda can't do cell wall synthesis" (e.g., "echi-no-candan").
Azoles: "The azoles will prevent ergosterol" (rhymes, implies they "mess up" the cell).
Amphotericin B: "Amphotericin a hole" (tears a hole in the plasma membrane).
Flucytosine: Mechanism is hinted at by the drug's name (flu-cytosine conversion to 5-fluoro-uracil by cytosine deaminase).
9:46 Side Effects of Amphotericin B: Being a potent drug, it has significant side effects, remembered by:
"Amphotericin phlebitis" (inflammation of the vein).
"Amphotericin, ah, ah, ah" (mimicking shivering from recurrent fever and chills, also fatigue).
"Amphlo-tericin" (alters the flow/permeability in the kidney nephron, leading to electrolyte imbalances like magnesium and potassium, and significant nephrotoxicity).